IAIM
RPRX icon

Industrial Alliance Investment Management’s Royalty Pharma RPRX Stock Holding History

Industrial Alliance Investment Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-91,650
Closed -$3.68M – 461
2022
Q3 		$3.68M Sell
91,650
-17,300
-16% -$739K 0.11% 167
2022
Q2 		$4.58M Sell
108,950
-1,150
-1% -$47.1K 0.13% 147
2022
Q1 		$4.29M Buy
+110,100
New +$4.32M 0.1% 173

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Industrial Alliance Investment Management's RPRX Position: Q4 2022 in Review

Industrial Alliance Investment Management sold out of Royalty Pharma (RPRX) in Q4 2022, closing a stake of 91,650 shares — an estimated $3.68M sold.

Industrial Alliance Investment Management first reported a position in RPRX in Q1 2022 and held it in 3 quarters. The position peaked at $4.58M in Q2 2022. 336 funds tracked by Wall St. Rank hold RPRX as of Q4 2022.

  • Industrial Alliance Investment Management reported no remaining Royalty Pharma position as of Q4 2022 after selling out during the quarter.
  • Industrial Alliance Investment Management sold 91,650 Royalty Pharma shares in Q4 2022, an estimated $3.68M.
  • Industrial Alliance Investment Management first reported a position in Royalty Pharma in Q1 2022 and held it in 3 quarters.
  • Industrial Alliance Investment Management's Royalty Pharma position peaked at $4.58M in Q2 2022.
  • 336 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2022.

Based on Industrial Alliance Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.